Immunohistochemical Markers for Prostatic Cancer

MEHRDAD NADJI; AZORIDES R. MORALES

doi:10.1111/j.1749-6632.1983.tb22197.x

Immunohistochemical Markers for Prostatic Cancer

MEHRDAD NADJI, AZORIDES R. MORALES

Pathology

Research output: Contribution to journal › Article

8 Scopus citations

Abstract

In a patient with an unclassifiable primary or metastatic neoplasm, with or without a history of prostatic cancer, immunostaining for PA or PSAP may prove invaluable. The procedure is simple, rapid, inexpensive, and extremely accurate in demonstrating the prostatic origin of tumors. It should be noted however, that the specificity of results is entirely dependent upon the specificity of the primary antibody, which should be meticulously defined before the procedure is used for diagnostic purposes.

Original language	English (US)
Pages (from-to)	134-139
Number of pages	6
Journal	Annals of the New York Academy of Sciences
Volume	420
Issue number	1
DOIs	https://doi.org/10.1111/j.1749-6632.1983.tb22197.x
State	Published - Dec 1983

Fingerprint

ASJC Scopus subject areas

Neuroscience(all)
Biochemistry, Genetics and Molecular Biology(all)
History and Philosophy of Science

Cite this

NADJI, MEHRDAD., & MORALES, AZORIDES. R. (1983). Immunohistochemical Markers for Prostatic Cancer. Annals of the New York Academy of Sciences, 420(1), 134-139. https://doi.org/10.1111/j.1749-6632.1983.tb22197.x

@article{c2daea5a826e464dab85383d902d8969,

title = "Immunohistochemical Markers for Prostatic Cancer",

abstract = "In a patient with an unclassifiable primary or metastatic neoplasm, with or without a history of prostatic cancer, immunostaining for PA or PSAP may prove invaluable. The procedure is simple, rapid, inexpensive, and extremely accurate in demonstrating the prostatic origin of tumors. It should be noted however, that the specificity of results is entirely dependent upon the specificity of the primary antibody, which should be meticulously defined before the procedure is used for diagnostic purposes.",

author = "MEHRDAD NADJI and MORALES, {AZORIDES R.}",

year = "1983",

month = dec

doi = "10.1111/j.1749-6632.1983.tb22197.x",

language = "English (US)",

volume = "420",

pages = "134--139",

journal = "Annals of the New York Academy of Sciences",

issn = "0077-8923",

publisher = "Wiley-Blackwell",

number = "1",

}

TY - JOUR

T1 - Immunohistochemical Markers for Prostatic Cancer

AU - NADJI, MEHRDAD

AU - MORALES, AZORIDES R.

PY - 1983/12

Y1 - 1983/12

N2 - In a patient with an unclassifiable primary or metastatic neoplasm, with or without a history of prostatic cancer, immunostaining for PA or PSAP may prove invaluable. The procedure is simple, rapid, inexpensive, and extremely accurate in demonstrating the prostatic origin of tumors. It should be noted however, that the specificity of results is entirely dependent upon the specificity of the primary antibody, which should be meticulously defined before the procedure is used for diagnostic purposes.

AB - In a patient with an unclassifiable primary or metastatic neoplasm, with or without a history of prostatic cancer, immunostaining for PA or PSAP may prove invaluable. The procedure is simple, rapid, inexpensive, and extremely accurate in demonstrating the prostatic origin of tumors. It should be noted however, that the specificity of results is entirely dependent upon the specificity of the primary antibody, which should be meticulously defined before the procedure is used for diagnostic purposes.

UR - http://www.scopus.com/inward/record.url?scp=0020974178&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020974178&partnerID=8YFLogxK

U2 - 10.1111/j.1749-6632.1983.tb22197.x

DO - 10.1111/j.1749-6632.1983.tb22197.x

M3 - Article

C2 - 6586093

AN - SCOPUS:0020974178

VL - 420

SP - 134

EP - 139

JO - Annals of the New York Academy of Sciences

JF - Annals of the New York Academy of Sciences

SN - 0077-8923

IS - 1

ER -

Access to Document

10.1111/j.1749-6632.1983.tb22197.x